Gliclazide (SR), Pioglitazone, and Metformin HCL (SR) """''"

Gliclazide (SR), Pioglitazone, and Metformin HCL (SR) 
TRIGLICLAGLAZE 60  are medications used in the management of type 2 diabetes mellitus. They work through different mechanisms to help control blood sugar levels. Here's an overview of each medication and how they are commonly used:
Gliclazide (SR):
Gliclazide is a sulfonylurea, which is a class of medications that stimulate the pancreas to produce more insulin.
Mechanism of Action: Gliclazide helps lower blood sugar levels by increasing the release of insulin from the pancreas. It also improves the sensitivity of cells to insulin.
Indications: Gliclazide is prescribed to individuals with type 2 diabetes to help control their blood sugar levels.
The "SR" in Gliclazide SR stands for "sustained release," which means the medication is formulated to provide a gradual and sustained release of the active ingredient throughout the day. The dosage can vary depending on the patient's needs and the specific product prescribed.
Common side effects may include low blood sugar (hypoglycemia), weight gain, and gastrointestinal symptoms. It's important for individuals taking Gliclazide to monitor their blood sugar levels regularly and be aware of the symptoms of low blood sugar.
Pioglitazone belongs to a class of medications called thiazolidinediones (TZDs) or glitazones.
Mechanism of Action: Pioglitazone works by improving insulin sensitivity in muscle and fat tissues. It helps the body use insulin more effectively and reduces the production of glucose by the liver.
Pioglitazone is used to treat type 2 diabetes. It is often prescribed when other medications alone are insufficient to control blood sugar levels.
The dosage of pioglitazone can vary depending on the individual and their response to treatment. It is usually taken orally in tablet form.
Common side effects may include weight gain, fluid retention, and a potential increase in the risk of heart failure. Regular monitoring of liver function and heart health is typically recommended during treatment.
Metformin HCL (SR):
Metformin is a biguanide medication.
Metformin primarily works by reducing the production of glucose by the liver and increasing insulin sensitivity in muscle tissues. It does not stimulate insulin release from the pancreas.
Metformin is commonly prescribed as a first-line treatment for type 2 diabetes. It is used to lower blood sugar levels and improve insulin sensitivity.
The "SR" in Metformin HCL SR stands for "sustained release," similar to Gliclazide SR. This means the medication provides a gradual and sustained release of the active ingredient over time. The dosage can vary depending on the individual and their specific needs.
Common side effects may include gastrointestinal symptoms such as nausea, diarrhea, and abdominal discomfort. Metformin is generally associated with a lower risk of hypoglycemia and weight gain compared to some other diabetes medications.
For further information please contact: 
info@sterispharma.com 
Order Now - https://www.sterisonline.com/product/trigliclaglaze-60-134279